Copyright
©The Author(s) 2022.
World J Gastroenterol. Jun 28, 2022; 28(24): 2680-2688
Published online Jun 28, 2022. doi: 10.3748/wjg.v28.i24.2680
Published online Jun 28, 2022. doi: 10.3748/wjg.v28.i24.2680
Ref. | CD, n | Pancreatitis prevalence | OR of AP | Outcome |
Alkhayyat et al[21], 2021 | 133400 | AP 1.06%; CP 0.52% | OR for AP = 2.66; OR for CP = 2.18 | Worse outcomes compared to non-CD |
Osagiede et al[24], 2020 | 337201 | AP 2.2% | OR = 1.92 | Lower morbidity and mortality, attributed to less severe forms of AP or lower baseline comorbidities |
Sadr-Azodi et al[22], 2012 | 28908 | Pancreatitis 1.4% | HR for gallstone-related AP = 1.59; HR for non-gallstone-related AP = 1.86; HR for CP = 3.33 | Increased risk of severe AP (gallstone-related: HR = 3.18; non-gallstone related: HR = 2.00) |
Ludvigsson et al[23], 2007 | 14239 | Pancreatitis any type 0.66% | HR for pancreatitis of any type = 3.3; HR for CP = 19.8 | Patient population was represented by hospital inpatients, leaving out those managed as outpatients |
No. | |
1 | Impaired secretion of cholecystokinin and secretin from the diseased small bowel mucosa |
2 | Reduced amino acid uptake in the small bowel, which subsequently leads to reduction in precursors for synthesis of pancreatic enzymes |
3 | Morphologic alterations in pancreatic parenchyma secondary to protein malnutrition |
- Citation: Balaban DV, Enache I, Ciochina M, Popp A, Jinga M. Pancreatic involvement in celiac disease. World J Gastroenterol 2022; 28(24): 2680-2688
- URL: https://www.wjgnet.com/1007-9327/full/v28/i24/2680.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i24.2680